New York’s Modus Capital Launches $75m MENA Fund Targeting Startups, SMEs

Print
 
Nov 2019
MENA, November, 04 2019 - The fund will invest in entities carrying a strong social impact, women-oriented firms and those focused on health, education and financial inclusion, the statement said.

New York based hybrid venture capital (VC) firm, Modus Capital, launched a $75m MENA fund targeting early and growth stage companies across the region.

The firm’s first regional fund, Modus MENA Venture Fund I (MMVFI) will also focus on the region’s SMEs and allocate funds for US-based firms portable to the MENA region.

The fund is designed to invest in early to lower-mid market asset stages, a statement said.

Modus Capital’s investments range from $50,000 to $250,000, and up to $1m for seed and series A rounds. The investments are made through an incubation programme.

The fund will invest in entities carrying a strong social impact, women-oriented firms and those focused on health, education and financial inclusion, the statement said.

Areas of fintech, healthtech, direct to consumer e-commerce, and enterprise and consumer SaaS products hold particular interest to the VC firm, it added.

Its current investments include iSupportCause – an online cause-based platform in the UAE; DXwand, an artificial intelligence driven cognitive CRM software; Arbor – a digitised business card app and Yumzy, a cooking tip app for home and professional chefs.

“We believe that institutional investors like Modus Capital have a responsibility to provide more than just funding to their portfolio companies and now is the right time to offer an all-inclusive solution, harnessing the global expertise for a dynamic MENA market,” said Kareem Elsirafy, founder and managing partner, Modus Capital.

VC investments across the MENA region are growing and reached $670m in 2018, according to a recent report by STV, a Riyadh-based technology VC fund.



Source : Gulf Business
 

Research Analysis Tools

The fund indexes, institution benchmarks and other market information displayed here are all Symbiotics designed analysis tools, created in-house by our analysts and experts. Symbiotics has one of the oldest track records in microfinance investment analysis dating back to the late 1990s; its indexes and benchmarks have been regularly used as markers by investors, asset managers, financial institutions and practitioners. These, as well as several other research products, are available through the Research Account. Click on the link below to find out more.

Learn More